STIVAX TREAT PAIN

STIVAX TREAT PAIN

Effectively improve the quality of life

  • FDA approved
  • Billing compliant
  • Non-narcotic
  • Extended Treatment Period
  • Adjustable Output
  • Water-Resistant

Stimulation Strength Increased or Decreased by Treating Physician

Physician may increase or decrease the current level delivered to the stimulation needles (array) as determined by diagnostic requirements and/or patient comfort.

Extended Treatment Period and Water Resistant Electronics

The Neurostimulator will function for 336 hours (14 days) with scheduled array changes and output adjustments during each treatment segment. The technology is water-resistant to facilitate patient hygiene, comfort, and diagnosis. (Full submersion/swimming is not recommended.)

Mechanism of Action via Stimulation of the Vagus Nerve

Outcomes indicate significant reductions in pain (Sf-12 /Oswestry) and improved perfusion of extremities often complicated by PAD (peripheral arterial occlusive disease).

Diagnosis and Installation of Device Can Be On the Same Day

Device may be installed in the same site visit concurrent with diagnostic testing or during an expedient time. Repositioning/adjustments and replacement can be performed within normal visit durations.

Neurostimulation TREATMENT for Pain/mobility, Tissue Oxygenation, Peripheral Artery Disease

TREATMENT

Because acute and chronic pain sufferers have different needs, Stivax output can be customized for each individual patient by diagnosis, comfort & tolerance. The initial application is designed to immediately mitigate pain and provide early relief. Array placement modifications and output adjustments may be made during structured follow up appointments. Protocol suggestions effectively utilize the devices 14 day output period and recommends 3 treatment cycles over a 60 day period. The additional treatments are adapted toward addressing each patient's needs.

Battery powered, and controlled by a microchip Stivax is minimally invasive and is utilized in an economical timeframe which can be performed in multiple environments. Once peripheral nerve access points are identified, the titanium electrodes of the array are attached to the access points, the waterproof electronics output can be adjusted, connected, and treatment initiated.

Randomized, controlled studies indicate that the majority of chronic pain patients describe at least 50% reduction in pain and further accumulation of pain reduction in subsequent treatments. Some patients, having solely relied upon narcotic drug therapies, have been able to discontinue the use of these conventional medicines.

A clinical trial by senior consultant Dr. Thomas Payrits on Vagus stimulation in PAD patients supports the effectiveness of STIVAX neurostimulation therapy. In addition to good data quality and a high level of patient compliance, study results show a significant rise in the transcutaneous partial pressure of oxygen between the initial examination and the final one.

The other parameters for efficacy and quality of life in the form of ABI SF-36 health surveys and the walking distance test also have similar results and thus confirm therapeutic success as an effective measure for improving the symptoms of PAD.

Available for your Practice

  • Simplified Online Credentialing
  • Listing In Patient Provider Identifier
  • Web-Enabled Orientation
  • On-Site Training Available
  • Billing & Compliance Assistance
  • Template, Forms & Use Guidance

Ease of Use (highlights only - all providers will receive detailed information)

The single Stivax package contains a single neurostimulation device that is used throughout the entire 14-day treatment. Protocols developed in cooperation with Compliance management will guide you on adjustments and placement. Common packaging bundles 3 devices together with adjunctive components to cover a 60 day treatment period.

Default package contents:

  • Water-resistant electronic stimulator
  • Multiple Swiss-made titanium needle arrays
  • Adhesive-backed clips for securing the stimulator to the patient
  • Array length estimators for approximating optimal shoulder placement
  • Several fixation plasters and alcohol swabs
  • Magnetic pin, used to change the output levels of the device
  • Clinical-grade disposal bags
  • One LED illuminator and light bender (optional installation aid included in first set-up kit)

The syndromes that may benefit from Peripheral Nerve or Field Stimulation include:

  • Peripheral Vascular Disease Neuropathy
  • Post-amputation Pain
  • Herpetic Neuralgia
  • Trigeminal Neuralgia
  • Reflex Sympathetic Dystrophy (RSD)
  • Peripheral Artery Disease (PAD)
  • Refractory Angina
  • Migraines
  • Occipital Neuralgia
  • Back and Neck Pain
  • Post-Surgical Pain
  • Complex Regional Pain Syndrome (CRPS)
  • Diabetic Peripheral Neuropathy
  • Lateral Femoral Cutaneous Neuropathy
  • Traumatic Nerve Injuries
  • Other conditions that have failed conventional therapies

Solace Advancement Institute direct importer of quality made Biegler Neurostimulation Technology